<p>Patients want clearer pricing, clinics want operational sustainability, managed care wants predictable cost control…</p><p>…and everyone wants more transparency.</p><p>This epiosde centers on the groundbreaking Journal of Assisted Reproduction and Genetics (JARG) paper on <a href="https://www.conceivable.life/research-papers/activity-based-costing-in-ivf-a-framework-for-transparency-and-operational-scaling-of-fertility-services" target="_blank" rel="noopener noreferer"><u><strong>Activity-Based Costing in IVF</strong></u></a><strong> </strong>and what it actually costs.</p><p>We’re joined by Pinnacle CFO Shruti Sood, The Fertility Partners CEO Heather Stark, and Chartis Partner Bret Anderson to discuss:</p><ul><li><p>Why IVF costs have not been accurately accounted for</p></li><li><p>How activity-based costing could reshape pricing models</p></li><li><p>The real impact of payer consolidation</p></li><li><p>Where clinics confuse capacity problems with volume problems</p></li><li><p>Whether different prognosis patients should be priced differently</p></li><li><p>How managed care pressure will change IVF economics</p></li></ul>